Eli Lilly and Co at Bank of America Global Healthcare Conference Transcript
Okay. Welcome to the second day of the BofA Healthcare Conference. My name is Geoff Meacham, and I'm the senior biopharma analyst here at BofA.
We're thrilled today to have Eli Lilly. And speaking on behalf of Lilly is Patrik Jonsson up on stage with me. He's Lilly's EVP and President, Immunology, Lilly USA, Chief Customer Officer, lots of titles.
Yes.
Questions & Answers
Patrik, give us -- from an I&I perspective, most investors have talked about Mounjaro and Alzheimer's. This is a franchise that has some differentiating assets. It has some -- a great pipeline. So maybe give us a higher level of that franchise and how valuable it is to Lilly today.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
